Correspondance: Waddell WJ,Thresholds in Chemical Carcinogenesis: What are Animal Experiments Telling Us?

Calabrese EJ , Baldwin LA -2003-. Hormesis: The dose-response revolution. Annu Rev Toxicol Pharmacol 43: 175—193.

Ashby J. , Morrod RS -1991-. Detection of human carcinogens. Nature 352: 185—186.

Fung VA , Barrett JC , Huff J. - 1995-. The carcinogenesis bioassay in perspective: Application in identifying human cancer hazards. Environ Health Perspect 103: 680—683.

Enomoto M. -2000-. A search for chemical agents causing human cancer-Lessons learned from rodent carcinogenicity studies-. J Toxicol Sci 25: 381— 392.

Williams GM , Iatropoulos MJ , Jeffrey AM -2000-. Mechanistic basis fornonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol Pathol 73: 394—402.

O'Connor PJ , Manning FCR , Gordon AT et al -2000-. DNA repair: Kinetics and thresholds. Toxicol Pathol 28: 375—381.

Fukushima S. , Wanibuchi H. , Morimura K. , et al -2002-. Lack of a dose-response for carcinogenicity in the rat liver with low doses of 2-amino-3, 8-dimethylimidazo [4, 5- f ] quinoxaline or N-nitrosodiethylamine. Jpn J Cancer Res 93: 1076—1082.

Enomoto M. -1985-. How does Japan differentiate hyperplasia from neoplasia? Toxicol Pathol 13: 110—118.

Coggins CRE -1998-. A review of chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol Pathol 26: 307—314.